Tech excites us – and if you’re taking your business to the next level through tech transactions, you need our knowledge of the technology itself as well as corporate expertise. Your company will be more successful when it maximises the value of technology and IP – a cornerstone of our practice.

To succeed in today’s fast-paced business environment you need advisers that bring a commercial outlook and market perspective from the get-go. Our focus on pre and post-transaction aspects such as planning and post-merger integration leave no stone unturned.

We believe in practical, proactive advice with a personal touch. Our 200 lawyers across Europe, Asia and the Middle East advise on all forms of corporate finance from private and public M&A, to private equity, IPOs and joint ventures together with all of the corporate governance and company advice needed.

We use tech solutions to underpin smart, useful advice that benefits our clients – not for the sake of it.

Whatever your size, stage in lifecycle or sector you’ll benefit from having our talented deal-makers onboard.

If you would like to know more about working with us, please contact Co-Heads Peter Veranneman in Germany and Stefano Silvestri in the United States. 

 

Recent highlights of work

  • Advised Darktrace, the machine-learning cyber security company, on its latest investment which tipped the company's value over the magical $1USD billion mark ($USD 1.25 billion), making it the firm's latest Unicorn.
  • Advised as Singapore counsel to Clearbridge Health, a medtech investor, on the proposed initial public offering of 88 million shares at 28 cents each on the Catalist board of the Singapore Exchange to raise net proceeds of S$21.4 million to build a business focused on precision medical services.
  • Advised US life sciences company Unchained Labs on the acquisition of German rap.ID Particle Systems GmbH. The transaction was managed in only four weeks, including due diligence, negotiations and notarization of the share purchase agreements with a focus on intellectual property rights. In connection with this transaction, Unchained Labs raised $17 million in a series D financing. Novo Ventures, Canaan Partners, TPG Biotech and Tri-Valley Ventures all participated in the financing.

Accolades

  • Band 1 in Hungary for Commercial, Corporate and M&A

    Legal 500 2018 EMEA

  • Band 1 listing for Cuba: Corporate/Commercial: Lawyers Based Abroad

    Chambers 2017 Latin America

  • Band 1 listing: Corporate and commercial – commercial contracts and Corporate and commercial – Venture capital

    Legal 500 2017 UK

  • Experienced AIM group capable of advising on IPOs, secondary fund-raisings and M&A transactions.

    Chambers UK 2017

  • The team continues to impress with its core of dedicated corporate practitioners with a niche expertise in the TMT and life sciences industries.

    Chambers Asia-Pacific

  • “… makes full use of its global network and full-service approach to provide a strong M&A practice.”

    Chambers Europe

  • ‘’One of the team’s strengths is that the lawyers have clear specialisations, and are very knowledgeable in their respective fields’’.

    Chambers Europe

  • Well versed in cross-border transactions in the TMT, healthcare, and energy and utilities sectors. Impressive client roster includes a number of highly active fast-growth companies.

    Chambers UK

  • Bird & Bird’s ‘strengths are industry knowledge, fast responses and competence’.

    Legal 500 EMEA

Related materials and downloads

News & Events

  1. 1007-2019

    Cybersecurity & Singapore - Mitigating risks posed by digitalised payments

    Given increased adoption of new technology for payment systems and within the financial ecosystem, the relevant authorities in Singapore have provided guidelines to mitigate cybersecurity risks. Despite adopting ...

  2. 0207-2019

    Cybersecurity & Singapore - Disclosures for Listed Companies

    With the spate of cybersecurity incidents on large listed companies, cybersecurity risk has increasingly become a key point that affects investor risk appetite and companies are now subject to certain disclosure ...

  3. 2706-2019

    Bird & Bird assists Addtech Group with the acquisition of Thiim A/S

    Bird & Bird assisted the Swedish Addtech Group during the M&A process of all shares outstanding in the Danish company Thiim A/S on 12 June 2019.

  1. 2706-2019

    Bird & Bird team up with more than 10 law firms to scale up solar power

    International law firm Bird & Bird teamed up with more than 10 law firms to scale up solar power as part of the Open Solar Contracts initiative, launched on 13 June 2019 at the African Energy Forum in Lisbon, Portugal

  2. 3005-2019

    International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera

    International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

  3. 2405-2019

    Bird & Bird advises FUJIFILM on the 100% acquisition of medwork

    International law firm Bird & Bird advises the FUJIFILM group on the acquisition of German medwork GmbH, a company that develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy.

View More Firm News

There are no forthcoming events for this area. Please click on the button below to view past events.

View more events